Neon Therapeutics, Inc.
Total raised
$106 M
1 round on record
Latest round
$106 M
Dec 2016
First round on record
Dec 2016
Today
Private
No later event on record
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2016 | $106 M | No. 1 | $50 to $250 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Neon Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2017).
SEC Form D · Dec 2017
The industry group it chose in its notices: Other Health Care.
SEC Form D · Dec 2017
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
8 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Access Industries Holdings LLC | Other | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Access Industries, LLC | Other | not stated | not stated | Held Series A and B preferred stock (Form 3, 2018) | SEC Form 3 |
| Access Industries Management, LLC | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock (Form 3, 2018) | SEC Form 3 |
| Clal Biotechnology Industries Ltd. | Company | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Hadley Harbor Master Investors (Cayman) L.P. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Third Rock Ventures GP III, L.P. | Venture capital | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Third Rock Ventures III, L.P. | Venture capital | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| TRV GP III, LLC | Other | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Hugh Dowd | Executive officer | Dec 2017 |
| Richard Gaynor, M.D. | Executive officer | Dec 2017 |
| Robert Ang, M.D. | Executive officer | Dec 2017 |
| Yasir Al-Wakeel | Executive officer | Dec 2017 |
| Daniella Beckman | Executive officer | Jan 2017 |
| Cary Pfeffer, M.D. | Director | Dec 2017 |
| Eric Lander | Director | Dec 2017 |
| Hugh Dowd | Director | Dec 2017 |
| Robert Kamen | Director | Dec 2017 |
| Robert Tepper | Director | Dec 2017 |
| Stephen Sherwin | Director | Dec 2017 |